This question is specific to Cerner hospitals. Patient specific labels have a barcode, which is great for compounded products where there is not a manufacturer barcode to scan during BCMA. However, on items were the manufacturer barcode should be used (unit dose, premix etc) the pt label can still be scanned. This makes mislabeling particularly risky if the label barcode is used rather than the drug product barcode. We are told by the vendor that it is not possible to remove the label barcode or differentiate products in the system that need them (or do not need them).

Hi,

We're struggling with our bar code scanning rate for Baxter's "Mini-bag Plus" containers. The bags have a white bar code, and our scanners won't read them if there is fluid behind the bar code or if there is a white label on the other side of the bag.

The only way that we can get the bar code to scan is if we squeeze the bag so that there is air behind the bar code AND also angle the scanner so that the flat water surface is below and serves as the background.

Does your institution allow Ciprodex to be allowed in trachostomy tubes? I've seen literature to support its use in preventing granulation tissue formation.

However, there has been some concerns brought up about the boric acid content of Ciprodex.

Has anyone had any discussions surrounding this?

Greetings,

A question has come up at our Radiology Clinic regarding patient's ability to drive home after receiving diphenhydramine for an allergic reaction. Does anyone have an institutional policy or standard of practice on this (e.g. patients are advised not drive for X hrs, or patients are not allowed to drive themselves, etc.)?

Thank you,
Daniel

We are in the process of rewriting the charter for our Medication Safety Committee. Does anyone have a charter for their organization that they are willing to share?

Thank you!
Vaishali

Interested in learning about safeguards that facilities stocking the phytonadione
1 mg ampule product have put in place.

General concerns we have identified at this point include:
1. mix-ups with phytonadion 10 mg ampule
2. mix-ups with methylergonovine ampule

Appreciate any insight to safeguards or risks you may have. TIA!

I am part of a 500+ bed, urban, academic organization. As far as antibiotic infusions go, we currently only run Zosyn as a primary infusion (run over 4 hours); our other antibiotic infusions are run as a primary/secondary set up. During the normal saline shortage, we ran all antibiotics primary and flushed with a 10 mL flush post infusion. Now that we are able to go back to our primary/secondary set up, we are getting some pushback from nursing.

How does your organization infuse IV antibiotics?

How do you draw up a patient-specific dose of an inhaled med? It is my understanding that the product needs to remain sterile, therefore doses should be drawn up in an ISO Class 5 environment into a sterile syringe.

1. Are you drawing up inhaled meds in your IV room hood?

2. Do you dispense them in an IV syringe, or an oral syringe?

3. If you do use oral syringes, are you using a STERILE oral syringe? If so, what manufacturer are you using? (Looking for sizes up to 10mL)

thank you for taking time to respond!

The package insert Westward brand injectable morphine specifically states 'for intravenous use' / for 'direct IV injection' - there is no reference to IM or subcutaneous routes.
https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/202515s000lbl.pdf
I'm soliciting feedback and rationale on whether the IM or Subcutaneous routes could be included in an EMR build (or not).

Curious to see what type of MRI compatible infusion pumps other hospitals are currently using? We are using IRadimed pumps at our facility.

Thank-you in advance for all who comments, much appreciated.

Natalie Zilban
Medication Safety Officer
Memorial Healthcare System
Hollywood, FL